March 25, 2020 / 8:55 PM / 8 days ago

BRIEF-Jazz Pharmaceuticals - PDUFA Goal Date For An FDA Decision For Jzp-258 Is July 21, 2020

Jazz Pharmaceuticals PLC:

* JAZZ PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR JZP-258 FOR CATAPLEXY AND EXCESSIVE DAYTIME SLEEPINESS ASSOCIATED WITH NARCOLEPSY

* JAZZ PHARMACEUTICALS - PDUFA GOAL DATE FOR AN FDA DECISION FOR JZP-258 IS JULY 21, 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below